SCHEMBL6838428

SCHEMBL6838428

COc1ccc(Sc2nc(N)nc3c2ncn3CCOC(P)(CC(F)(F)F)CC(F)(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD3 Q9BZ95 2/20 0.40
SLC29A1 Q99808 3/20 0.38
DHFR P00374 2/20 0.37
CYP1A2 P05177 5/20 0.37
CYP2C19 P33261 4/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
HIF1A Q16665 2/20 0.37
CYP2D6 P10635 1/20 0.37
ADORA2A P29274 1/20 0.37
HSP90AA1 P07900 2/20 0.36
HSP90AB1 P08238 2/20 0.36
NSD2 O96028 1/20 0.35
HSP90B1 P14625 1/20 0.35
ALDH1A1 P00352 1/20 0.34
PHLPP2 Q6ZVD8 1/20 0.34
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15532061 0.92 SLC29A1 (0.40) NSD3SLC29A1DHFRCYP1A2CYP2C19
SCHEMBL15532145 0.91 SLC29A1 (0.41) NSD3SLC29A1DHFRCYP1A2CYP2C19
SCHEMBL15532188 0.91 SLC29A1 (0.44) NSD3SLC29A1DHFRCYP1A2CYP2C19
SCHEMBL7596236 0.91 SLC29A1 (0.39) NSD3SLC29A1DHFRCYP1A2CYP2C19
SCHEMBL15532327 0.91 SLC29A1 (0.37) NSD3SLC29A1DHFRCYP1A2CYP2C19
SCHEMBL15531950 0.90 CYP1A2 (0.38) NSD3SLC29A1DHFRCYP1A2CYP2C19
SCHEMBL7769278 0.90 DHFR (0.41) NSD3SLC29A1DHFRCYP1A2CYP2C19
SCHEMBL7765668 0.89 SLC29A1 (0.43) NSD3SLC29A1CYP1A2CYP2C19CYP3A4
SCHEMBL15532048 0.86 CYP2C19 (0.38) NSD3SLC29A1DHFRCYP1A2CYP2C19
SCHEMBL7765688 0.84 SLC29A1 (0.41) SLC29A1DHFRCYP1A2CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040023928-A1 Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox COLACINO JOSEPH MATTHEW (US) 2004-02-05 US claimed
EP-2846788-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN Akron Molecules AG (AT) 2015-03-18 EP disclosed
WO-2013167743-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN AKRON MOLECULES GMBH (AT) 2013-11-14 WO disclosed
US-20040023928-A1 Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox COLACINO JOSEPH MATTHEW (US) 2004-02-05 US disclosed
EP-0785208-B1 Phosphonate nucleotide compounds MITSUBISHI CHEM CORP (JP) 2001-03-21 EP disclosed
EP-0785208-A1 Phosphonate nucleotide compounds MITSUBISHI CHEMICAL CORPORATION (JP) 1997-07-23 EP disclosed